Prevention of Sporadic Colorectal Adenomas With Celecoxib

Trial Profile

Prevention of Sporadic Colorectal Adenomas With Celecoxib

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jan 2017

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Colorectal cancer; Polyps; Sporadic adenomas
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms APC
  • Most Recent Events

    • 21 Jan 2017 Results of a biomarker analysis presented at the 2017 Gastrointestinal Cancers Symposium.
    • 22 Apr 2013 Endpoints updated (ex VANS).
    • 11 Apr 2013 Planned number of patients changed from 1000 to 1170 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top